Multicenter phase II study of FOLFIRI and bevacizumab as second-line treatment in advanced or recurrent colorectal cancer.
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2015
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms PROMETEUS-II
- Sponsors Yakult Honsha
- 02 Apr 2009 New trial record.